Triad Pro Innovators Inc (CE) (TPII)
USOTC
Fin d'année 28 Février 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -95.053 | -120.299 | -444.338 | -458.994 | -159.072 |
Return on Equity (%) | -124.174 | -212.195 | -1971.09 | -1135.629 | -1072.843 |
Return on Invested Capital (%) | -148.035 | -141.096 | -922.807 | -492.308 | -1148.276 |
Operating Margin (%) | -358.217 | -1290.419 | -25906.25 | -21435 | -1140.411 |
Net Profit Margin (%) | -361.281 | -1302.395 | -25993.75 | -21435 | -1150 |
Book Value Per Share | 0.034 | -0.009 | N/A | -0.001 | -0.001 |
Earnings Per Share | -0.027 | -0.042 | -0.023 | -0.024 | -0.004 |
Cash Per Share | N/A | 0.001 | N/A | N/A | N/A |
Working Capital Per Share | -0.01 | -0.015 | N/A | -0.001 | -0.001 |
Operating Profit Per Share | 0.002 | 0.003 | N/A | N/A | N/A |
EBIT Per Share | -0.027 | -0.042 | -0.023 | -0.024 | -0.004 |
EBITDA Per Share | -0.027 | -0.042 | -0.023 | -0.024 | -0.004 |
Free Cash Flow Per Share | -0.046 | -0.064 | -0.025 | -0.024 | -0.004 |
Fin d'année 28 Février 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 47,22M | 50,79M | 178,74M | 178,74M | 436,96M |
Capitalisation boursière | 37,04k |
Ratio cours/bénéfice | 0 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0 |
Ratio prix/valeur comptable | 0 |
Rendement de dividende | - |
Actions en circulation | 370,43M |
Volume moyen (1 semaine) | 74,55k |
Volume moyen (1 mois) | 300,63k |
Variation sur 52 semaines | -94,12% |
Plus haut sur 52 semaines | 0,0049 |
Plus bas sur 52 semaines | 0,000001 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales